Approval · Notice of Compliance 11354 · 2010
MORPHINE SR: Notice of Compliance 11354
Issued May 6, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11354
- Date
- May 6, 2010
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Opioid analgesic
- Canadian reference product
- MS CONTIN (Purdue Pharma)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MORPHINE SR | 02350815 | Cancelled Post Market |
| MORPHINE SR | 02350890 | Cancelled Post Market |
| MORPHINE SR | 02350912 | Cancelled Post Market |
| MORPHINE SR | 02350920 | Cancelled Post Market |
| MORPHINE SR | 02350947 | Cancelled Post Market |
Medicinal ingredients
- MORPHINE SULFATE 15 MG per TAB
- MORPHINE SULFATE 30 MG per TAB
- MORPHINE SULFATE 60 MG per TAB
- MORPHINE SULFATE 100 MG per TAB
- MORPHINE SULFATE 200 MG per TAB